We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Nostrum Labs Agrees to Pay Up to $50 Million Over Underpayment of Medicaid Rebates
Nostrum Labs Agrees to Pay Up to $50 Million Over Underpayment of Medicaid Rebates
Nostrum Laboratories and its CEO have struck a potential $50 million settlement with the Department of Justice (DOJ) to resolve allegations the company knowingly underpaid Medicaid rebates for its Nitrofurantoin Oral Suspension (Nitro OS) generic product.
